Status:
UNKNOWN
The Nanowear Wearable Covid-19 Observational and Analysis Trend
Lead Sponsor:
Nanowear Inc.
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
The NanoCOAT study is a multi-center, prospective, non-randomized, feasibility, observational, non-significant risk study. The NanoCOAT study will enroll a minimum of 10 and a maximum of 100 subjects ...
Eligibility Criteria
Inclusion
- Subject has provided informed consent
- Male or female over the age of 18 years
- The patient is currently hospitalized with a primary diagnosis of Covid-19
Exclusion
- Subject is unwilling or unable to wear the vest during hospitalization.
- Subjects who are pregnant.
- Subject is intubated or admitted to ICU
- Subject has an implantable cardiac device (i.e pacemaker or internal cardioverter defibrillator)
Key Trial Info
Start Date :
September 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04717024
Start Date
September 15 2020
End Date
December 31 2023
Last Update
November 8 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hackensack University Medical Center
Hackensack, New Jersey, United States, 07601
2
Maimonides Medical Center
Brooklyn, New York, United States, 11219